<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Appl Microbiol Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">Appl Microbiol Biotechnol</journal-id><journal-title-group><journal-title>Applied Microbiology and Biotechnology</journal-title></journal-title-group><issn pub-type="ppub">0175-7598</issn><issn pub-type="epub">1432-0614</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8072733</article-id><article-id pub-id-type="pmid">33900425</article-id><article-id pub-id-type="publisher-id">11288</article-id><article-id pub-id-type="doi">10.1007/s00253-021-11288-w</article-id><article-categories><subj-group subj-group-type="heading"><subject>Mini-Review</subject></subj-group></article-categories><title-group><article-title>Peculiarities of promiscuous <sc>l</sc>-threonine transaldolases for enantioselective synthesis of &#x003b2;-hydroxy-&#x003b1;-amino acids</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Shan</given-names></name><address><email>shan.wang@abdn.ac.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0047-0622</contrib-id><name><surname>Deng</surname><given-names>Hai</given-names></name><address><email>h.deng@abdn.ac.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.7107.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7291</institution-id><institution>Department of Chemistry, </institution><institution>University of Aberdeen, </institution></institution-wrap>Aberdeen, Scotland AB24 3UE UK </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="ppub"><year>2021</year></pub-date><volume>105</volume><issue>9</issue><fpage>3507</fpage><lpage>3520</lpage><history><date date-type="received"><day>17</day><month>2</month><year>2021</year></date><date date-type="rev-recd"><day>31</day><month>3</month><year>2021</year></date><date date-type="accepted"><day>7</day><month>4</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2021</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Abstract</title><p id="Par1">The introduction of &#x003b2;-hydroxy-&#x003b1;-amino acids (&#x003b2;HAAs) into organic molecules has received considerable attention as these molecules have often found widespread applications in bioorganic chemistry, medicinal chemistry and biomaterial science. Despite innovation of asymmetric synthesis of &#x003b2;HAAs, stereoselective synthesis to control the two chiral centres at C<sub>&#x003b1;</sub> and C<sub>&#x003b2;</sub> positions is still challenging, with poor atomic economy and multi protection and deprotection steps. These syntheses are often operated under harsh conditions. Therefore, a biotransformation approach using biocatalysts is needed to selectively introduce these two chiral centres into structurally diverse molecules. Yet, there are few ways that enable one-step synthesis of &#x003b2;HAAs. One is to extend the substrate scope of the existing enzyme inventory. Threonine aldolases have been explored to produce &#x003b2;HAAs. However, the enzymes have poor controlled installation at C<sub>&#x003b2;</sub> position, often resulting in a mixture of diastereoisomers which are difficult to be separated. In this respect, <sc>l</sc>-threonine transaldolases (LTTAs) offer an excellent potential as the enzymes often provide controlled stereochemistry at C<sub>&#x003b1;</sub> and C<sub>&#x003b2;</sub> positions. Another is to mine LTTA homologues and engineer the enzymes using directed evolution with the aim of finding engineered biocatalysts to accept broad substrates with enhanced conversion and stereoselectivity. Here, we review the development of LTTAs that incorporate various aldehyde acceptors to generate structurally diverse &#x003b2;HAAs and highlight areas for future developments.</p></sec><sec><title>Key points</title><p id="Par2">&#x02022; <italic>The general mechanism of the transaldolation reaction catalysed by LTTAs</italic></p><p id="Par3">&#x02022; <italic>Recent advances in LTTAs from different biosynthetic pathways</italic></p><p id="Par4">&#x02022; <italic>Applications of LTTAs as biocatalysts for production of &#x003b2;HAAs</italic></p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><sc>l</sc>-threonine transaldolases (LTTAs)</kwd><kwd>&#x003b2;-Hydroxy-&#x003b1;-amino acids (&#x003b2;HAAs)</kwd><kwd>Stereoselective chemoenzymatic synthesis</kwd><kwd>Natural product biosynthesis</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>BB/P00380X/1</award-id><award-id>BB/R00479X/1</award-id><award-id>BB/R50547X/1</award-id><principal-award-recipient><name><surname>Deng</surname><given-names>Hai</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000360</institution-id><institution>Scottish Funding Council</institution></institution-wrap></funding-source><award-id>COVID 19 grant extension and Bridging Fung</award-id><principal-award-recipient><name><surname>Deng</surname><given-names>Hai</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>IBIOIC</institution></funding-source><award-id>PhD studentship</award-id><principal-award-recipient><name><surname>Deng</surname><given-names>Hai</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Germany, part of Springer Nature 2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction and scope of the review</title><p id="Par5">Nature often employs non-canonical amino acids that bear new and different functional groups to tune the properties of bioactive small molecules (Hibi et al. <xref ref-type="bibr" rid="CR18">2015</xref>). There are dozens of known modifications to proteogenic amino acids, including a wide variety that bears a hydroxyl group at the &#x003b2;-carbon. &#x003b2;-Hydroxy-&#x003b1;-amino acids (&#x003b2;HAAs) are an important class of compounds, the majority of which contain two chiral centres at C<sub>&#x003b1;</sub> and C<sub>&#x003b2;</sub> position, resulting in four possible diastereoisomers (Ashford and Bew <xref ref-type="bibr" rid="CR1">2012</xref>). They are valuable constituents of medicinally important compounds and complex natural products (Hibi et al. <xref ref-type="bibr" rid="CR18">2015</xref>). For instance, <sc>l</sc>-<italic>threo</italic>-3,4-dihydroxyphenylserine (Droxidopa) <bold>1</bold> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) is a currently used therapeutic for the treatment of Parkinson disease (Maruyama et al. <xref ref-type="bibr" rid="CR28">1996</xref>; Hauser et al. <xref ref-type="bibr" rid="CR17">2016</xref>). &#x003b2;HAAs have also been used as intermediates in the biosynthesis of &#x003b2;-lactones such as obafluorin <bold>2</bold> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) (Schaffer et al. <xref ref-type="bibr" rid="CR40">2017</xref>; Scott et al. <xref ref-type="bibr" rid="CR41">2017</xref>). <sc>l</sc>-<italic>threo</italic>-<italic>p</italic>-nitrophenylserine and its derivative are the key components of amino alcohol antibiotics, chloramphenicol <bold>3</bold> (Seiple et al. <xref ref-type="bibr" rid="CR42">2014</xref>), its synthetic derivatives thiamphenicol <bold>4a</bold> and fluorfenicol <bold>4b</bold> and 4-fluorothreonine <bold>5</bold> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) (Lu et al. <xref ref-type="bibr" rid="CR26">2008</xref>); &#x003b2;-hydroxytyrosine and &#x003b2;-hydroxyphenylalanine residues are found in clinically active glycopeptide antibiotics, such as vancomycin <bold>6</bold> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) (Yim et al. <xref ref-type="bibr" rid="CR55">2014</xref>). Nucleotide-containing &#x003b2;HAA is the crucial motif of the nucleoside antibiotic natural products <bold>7</bold>&#x02013;<bold>9</bold> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) (Barnard-Britson et al. <xref ref-type="bibr" rid="CR3">2012</xref>; Cai et al. <xref ref-type="bibr" rid="CR4">2015</xref>; Ushimaru and Liu <xref ref-type="bibr" rid="CR46">2019</xref>). &#x003b2;HAAs are also common synthetic precursors to &#x003b2;-lactams and aziridine carboxylic acid derivatives in synthetic chemistry and to chiral bisoxazoline ligands for metal catalysis (Masruri et al. <xref ref-type="bibr" rid="CR29">2012</xref>).
<fig id="Fig1"><label>Fig. 1</label><caption><p>&#x003b2;-hydroxy-&#x003b1;-amino acids (&#x003b2;HAAs) serve as building blocks for many biological active chemicals and pharmaceutical drugs</p></caption><graphic xlink:href="253_2021_11288_Fig1_HTML" id="MO1"/></fig></p><p id="Par6">These diverse applications underlie a broad interest in understanding &#x003b2;HAA production and utilization in nature. Accordingly, several methods have been devised for the asymmetric syntheses of &#x003b2;HAAs including asymmetric aldol reaction (Sugiyama et al. <xref ref-type="bibr" rid="CR44">2002</xref> and Singjunla et al. <xref ref-type="bibr" rid="CR43">2013</xref>), sharpless asymmetric dihydroxylations (Masruri et al. <xref ref-type="bibr" rid="CR29">2012</xref>), stereoselective electrosynthesis using <italic>trans</italic>-metal Schiff base complexes (Levitskiy et al. <xref ref-type="bibr" rid="CR25">2019</xref>) and numerous others. The main challenge is the control of the relative and absolute stereochemistry of the asymmetric carbons in the current trend of sustainable development.</p><p id="Par7">Compared to non-enzymatic synthesis, an attractive alternative is enzymatic synthesis of &#x003b2;HAAs via a one-step process under mild conditions as a means of potentially more atom-economic and greener. There have been considerable attentions that are focused on those promising biotransformation strategies for asymmetric synthesis of &#x003b2;HAAs. Nature has evolved different enzymatic routes to produce these useful compounds. Free amino acids can undergo stereo-specific and -selective C&#x003b2; hydroxylation, as illustrated by the non-heme Fe-dependent hydroxylation of homotyrosine in the biosynthesis of echinocandins (H&#x000fc;ttel. <xref ref-type="bibr" rid="CR21">2021</xref>). Another common biosynthetic strategy is for an amino acid to be loaded onto a non-ribosomal peptide synthetase (NRPS), whereupon a P450 enzyme catalyses C&#x003b2; hydroxylation of an aminoacyl-<italic>S</italic>-enzyme intermediate en-route to a peptide natural product as observed in the biosynthesis of vancomycin <bold>1</bold> (Tailhades et al. <xref ref-type="bibr" rid="CR45">2020</xref>).</p><p id="Par8">Threonine aldolases (TAs), which catalyse a reversible chemical reaction of cleavage of threonine into glycine and acetaldehyde, have been reported as such biocatalysts using various aldehydes and glycine as substrates to generate useful &#x003b2;HAAs (Fesko <xref ref-type="bibr" rid="CR13">2016</xref>). However, the poor enantioselectivity at C<sub>&#x003b2;</sub> hampers their further application as side products are generated. In contrast, there is a remarkable set of pyridoxal-5&#x02032;-phosphate (PLP)-dependent enzymes, <sc>l</sc>-threonine transaldolases (LTTAs), which catalyse retroaldol cleavage of <sc>l</sc>-threonine (Thr) and a subsequent aldol-like addition into an aldehyde to form a new side chain, setting the stereochemistry of the C<sub>&#x003b2;</sub>&#x02212;OH group. It is worth noting that phylogenetic analysis suggested that LTTAs are evolutionary distinct from <sc>l</sc>-threonine aldolases (LTAs) and SHMTs (Scott et al. <xref ref-type="bibr" rid="CR41">2017</xref>; Wu et al. <xref ref-type="bibr" rid="CR51">2020</xref>).</p><p id="Par9">This review surveys the recent advances of LTTAs discovered in the biosynthetic pathways as potential biocatalysts, highlighting the unique biochemical transformations and their substrate promiscuity. Particular emphasis is placed on exploring the existing LTTA inventory for the production of structurally diverse &#x003b2;HAAs. Furthermore, bioengineering of such enzymes will certainly advance our abilities to engineer a suitable biotechnologically viable catalyst for &#x003b2;HAA production. Other PLP-dependent enzymatic reactions discovered from natural product biosynthesis can be found in the recent review (Du and Ryan <xref ref-type="bibr" rid="CR11">2019</xref>). Another family of transaldolases from the pentose phosphate pathway, catalysing the reversible transfer of a dihydroxyacetone moiety between ketose donors and aldose acceptors (<sc>d</sc>-glyceraldehyde-3-phosphate, or <sc>d</sc>-erythrose-4-phosphate), was summarized in a review (Samland et al. <xref ref-type="bibr" rid="CR38">2011</xref>). Therefore, this group of transaldolases will be out of the scope in the current report.</p><p id="Par10">Although the first LTTA, 4-fluorothreonine transaldolase (FTase), was identified in 2001 (Murphy et al. <xref ref-type="bibr" rid="CR32">2001</xref>), it was not until 11 years later in 2012 that a second LTTA was identified (Barnard-Britson et al. <xref ref-type="bibr" rid="CR3">2012</xref>). Since then, five new LTTA homologues have been discovered during the biosynthetic studies of various bioactive natural products, coincided with the advanced genome sequencing technology during the last decade. It is noteworthy that while FTases are didomain LTTAs, newly discovered LTTAs are single-domain enzymes. Automated annotation of the sequenced genomes has miscategorized many LTTA-like open reading frames (ORFs) in microbial genomes as serine hydroxymethyltransferase (SHMT)-like enzymes (Scott et al. <xref ref-type="bibr" rid="CR41">2017</xref>). However, these LTTA-like ORFs share low homologues (25&#x02013;35% aa identity) to SHMTs. Therefore, new LTTA homologues with improved kinetics and broad substrate specificity could be identified and characterized through conserved genomic mining of biotechnological purpose for asymmetric synthesis of &#x003b2;HAAs. This review will serve as a compendium to communities of microbiologists, organic chemists, natural product chemists, biochemists, synthetic biologists, and many others interested in the subject.</p></sec><sec id="Sec2"><title>The general mechanism of LTTAs</title><p id="Par11">All of the LTTA enzymes utilize PLP as the cofactor. The catalytic cycle starts and ends with the same PLP cofactor form (the internal aldimine <bold>10</bold>), which is derived from transamination and heterolytic cleavage to maintain the carbanionic intermediates (Richard et al., <xref ref-type="bibr" rid="CR37">2009</xref>). The internal aldimine structure consists of an imine linkage between the amino group of a lysine residue from the enzyme and the aldehyde carbon of free PLP. Then, within the interaction of <sc>l</sc>-Thr, a geminal diamine intermediate <bold>11</bold> is formed which finally leads to the PLP:external aldimine <bold>12</bold> allowing substrate binding and product release (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Additionally, the proton in the external aldimine can transfer (or is shared) between oxygen in the pyridine ring and imine nitrogen forming two tautomeric isoforms, enolimine <bold>12</bold> and ketoenamine <bold>12a</bold> separately. This transformation shows specific maximal absorbance values at 335 nm for enolimine <bold>12a</bold> and 425 nm for ketoenamine <bold>12</bold> when analysed by ultraviolet-visible (UV-Vis) spectroscopy.
<fig id="Fig2"><label>Fig. 2</label><caption><p><bold>a</bold> A generic mechanism of the transaldolation reaction catalysed by LTTAs. <bold>b</bold> The schematic representation of Dunathan intermediate <bold>12a</bold> and quinonoid intermediate <bold>13a</bold></p></caption><graphic xlink:href="253_2021_11288_Fig2_HTML" id="MO2"/></fig></p><p id="Par12">The PLP:external aldimine <bold>12</bold> is the crucial intermediate for all LTTAs. Meanwhile, the efficiency of the PLP enzymatic reaction is predominately dependent on the heteroaromatic pyridine ring. The electrophilicity of the C4 of the external aldimine is enhanced because of the protonated pyridinium nitrogen, the resonance and hydrogen bonding of the hydroxyl group, leading to an &#x02018;electron sink&#x02019;. Therefore, the protonated imine nitrogen can withdraw electrons from the substrate. The &#x003c0;-conjugation of the pyridine ring delocalizes and stabilizes the net-negative charge of external aldimine. Due to the electronic delocalization energy, the stereochemical rearrangement of &#x003c3; bonds is activated by a &#x003c0; system, forming the Dunathan intermediate <bold>12b</bold> (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). The deprotonation of hydroxyl group at C&#x003b2; of <sc>l</sc>-Thr residue results in a retroaldol cleavage between the C<sub>&#x003b1;</sub>-C<sub>&#x003b2;</sub> bond, promoting the bond-breaking process of the perpendicular bond of the pyridine ring <bold>13a</bold> (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). As a consequence, the heterolytic cleavage happens, and the C<sub>&#x003b1;</sub> hybridization changes generate the resonance-stabilized ubiquitous quinonoid intermediate <bold>13</bold> which displays specific maximal absorbance values at 495 nm. However, the quinonoid intermediate has not always been observed by UV-Vis spectroscopy in many the PLP-dependent reactions, suggesting that they may be extremely short lived or transient. A subsequent aldol-like addition into an aldehyde forms a new side chain <bold>14</bold>, setting the stereochemistry of the C&#x003b2;-OH group to yield new <sc>l</sc>-threo-&#x003b1;-hydroxy-&#x003b2;-amino acids <bold>15</bold> after hydrolysis (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). It is worth noting that LTTAs are evolutionarily divergent from TAs as such the first half of the biochemical pathway of LTTAs processes a retroaldol reaction, significantly different from TAs.</p></sec><sec id="Sec3"><title>Discovery of <sc>l</sc>-Thr transaldolases from the biosynthetic pathways of natural products</title><sec id="Sec4"><title>The discovery of the didomain 4-fluorothreonine transaldolases (FTases)</title><p id="Par13">Fluorine has emerged as a privileged element in medicinal chemistry as well as in agrochemistry and materials science (O&#x02019;Hagan and Deng <xref ref-type="bibr" rid="CR34">2015</xref>). Fluorine substitutions are now considered a standard strategy for modulating the properties of chemical leads, despite that environmental contamination by organofluorines is an issue of major concern due to their persistence to biodegradation (Moreira et al. <xref ref-type="bibr" rid="CR30">2018</xref>). While many chemical methods of selective synthesis of organofluorines have been developed, it is attractive to consider biotransformation approaches to selectively access novel organofluorine chemicals, rather than using challenging chemical methods (Wu et al. <xref ref-type="bibr" rid="CR49">2020</xref>). Fluorinated NPs are rare, mainly due to the highest heat hydration of fluoride in water which makes fluoride a poor nucleophile. As a result, there are only a handful of fluorinated natural products discovered by organic chemists in natural product inventory. 4-Fluorothreonine (4-FT) <bold>5</bold> is the only fluorinated amino acid natural product discovered thus far. It was found to be a co-occurrent metabolite with another fluorinated toxic, fluoroacetate (FAc) <bold>16</bold>, in the culture broth of the soil bacterium <italic>Streptomyces cattleya</italic> in 1986 (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>) (Sanada et al. <xref ref-type="bibr" rid="CR39">1986</xref>). O&#x02019;Hagan and co-workers have conducted the seminal work on elucidation of the fluorometabolism in <italic>S. cattleya</italic> (Deng et al. <xref ref-type="bibr" rid="CR9">2004</xref>). They demonstrated that fluoroacetaldehyde (FAd) <bold>17</bold> is the precursor of 4-FT (Hamilton et al. <xref ref-type="bibr" rid="CR15">1997</xref>; Nieschalk et al. <xref ref-type="bibr" rid="CR33">1997</xref>; Moss et al. <xref ref-type="bibr" rid="CR31">2000</xref>), but glycine is not directly contributed to the 4-FT biosynthesis (Hamilton et al. <xref ref-type="bibr" rid="CR16">1998</xref>) in their early isotopic labelling studies, suggesting that the biotransformation of FAd <bold>17</bold> to 4-FT <bold>5</bold> is not descended from a classical aldolase reaction. In 2001, the enzyme, 4-fluorothreonine transaldolase (4-FTase), responsible for the production of 4-FT, was purified from <italic>S. cattleya</italic> (Murphy et al. <xref ref-type="bibr" rid="CR32">2001</xref>). Biochemical analysis using a combination of isotopic labelling experiments and GC-MS analysis demonstrated that this wild-type enzyme actually catalyses a PLP-dependent cross-over transaldolation reaction between FAd and <sc>l</sc>-Thr to give 4-FT and acetaldehyde as shown in Fig. <xref rid="Fig3" ref-type="fig">3a</xref>. The hallmark of the fluorometabolism studies is the discovery of the first native fluorination enzyme, fluorinase (FlA), which catalyses C-F bond formation between fluoride ion and <italic>S</italic>-adenosyl-<sc>l</sc>-methionine (SAM) <bold>18</bold> to generate 5&#x02032;-fluoro-5&#x02032;-deoxyadenosine <bold>19</bold> (O&#x02019;Hagan et al. <xref ref-type="bibr" rid="CR35">2002</xref>; Dong et al. <xref ref-type="bibr" rid="CR10">2004</xref>). <bold>19</bold> is the first committed fluorinated intermediate in the 4-FT and FAc biosynthetic pathway. Sequence analysis of the cosmid DNA containing the <italic>fl</italic>A gene indicated that the gene-encoded FTase is not in the close proximity of <italic>fl</italic>A (Huang et al. <xref ref-type="bibr" rid="CR19">2006</xref>). To identify and clone the gene encoding FTase, degenerate PCR primers were designed based on MS-MS amino acid sequencing of FTase purified from <italic>S. cattleya</italic>. Subsequent chromosomal walking strategy allowed identification of a 1905 bp open-reading frame (<italic>orf</italic>). The encoded gene product contains 634 amino acids (aa), composed of two domains. The larger domain (S-domain) in the <italic>N</italic>-terminal shares ~44% sequence identity with SHMTs from archaea and thermophilic bacteria, while the smaller one (A-domain) in the C-terminal displays homology (~28% aa identity) with bacterial ribulose-1-phosphate-4-epimerase (Deng et al. <xref ref-type="bibr" rid="CR7">2008</xref>). It appears that FTase has a hybrid construction with key binding motifs from these distinct enzymes. The <italic>flFT</italic> gene was introduced into the model strain, <italic>S. lividans</italic> TK24, for overexpression. Although the enzyme expression level was low, incubation of recombinant enzyme with <sc>l</sc>-Thr and FAd <bold>17</bold> generated 4-FT <bold>5</bold> as monitored in <sup>19</sup>F-NMR. <italic>In vitro</italic> pathway reconstitution indicated that fluoride ion can be converted to 4-FT involving five overexpressed enzymes, including recombinant fluorinase and FTase (Deng et al. <xref ref-type="bibr" rid="CR7">2008</xref>). Inactivation of <italic>flFT</italic> in <italic>S. cattleya</italic> resulted in the sole production of fluoroacetate (Zhao et al. <xref ref-type="bibr" rid="CR56">2012</xref>), further confirming the role of FTase in 4-FT biosynthesis.
<fig id="Fig3"><label>Fig. 3</label><caption><p><bold>a</bold> The biosynthetic pathways of 4-fluorothreonine and fluoroacetate, highlighted with the first committed enzymatic step in the pathway of the fluorination enzyme. The fluorinase (FlA) in <italic>Streptomyces cattleya</italic> and <italic>Streptomyces</italic> sp. MA37 (MA37). <bold>b</bold> FTaseMA from MA37, the close homologue of the original FTase identified in <italic>S. cattleya</italic>, displays broad substrate specificity toward various aldehyde acceptors. <bold>c</bold> The proposed mechanism of the dehydration of FAd hydrate <bold>17a</bold> to FAd aldehydic form <bold>17</bold> catalysed by the second small domain of FTaseMA for the transaldolation reaction</p></caption><graphic xlink:href="253_2021_11288_Fig3_HTML" id="MO3"/></fig></p><p id="Par14">The genome sequencing efforts of the second decade of the twenty-first century have revealed that another four actinomycete strains encode the <italic>flA</italic> genes, suggesting that these four new strains may have capacity to produce fluorometabolites (Deng et al. <xref ref-type="bibr" rid="CR8">2014</xref>; Huang et al. <xref ref-type="bibr" rid="CR20">2014</xref>; Wang et al. <xref ref-type="bibr" rid="CR47">2014</xref>). Of particular relevance here is the strain isolated from a Ghanaian soil sample, <italic>Streptomyces</italic> sp. MA37. In culture, the organism had the capacity to biosynthesise 4-FT <bold>5</bold> and FAc <bold>16</bold>, as well as a range of other minor fluorometabolites (Ma et al. <xref ref-type="bibr" rid="CR27">2015</xref>; Wu et al. <xref ref-type="bibr" rid="CR50">2020</xref>). The <italic>flFT</italic> homologues encoding the last step of 4-FT biosynthesis are in close proximity to the corresponding <italic>flA</italic> homologue, in line with expectation. This is not the case for <italic>S. cattleya</italic>, where <italic>flFT</italic> is located on the megaplasmid pSCATT (1.8 Mbp in length) and the <italic>flA</italic> gene is on the chromosome of <italic>S. cattleya</italic> (Zhao et al. <xref ref-type="bibr" rid="CR56">2012</xref>).</p><p id="Par15">More recently, the overexpression of <italic>flFT</italic> homologous gene (<italic>flFTMA</italic>) from <italic>Streptomyces sp.</italic> MA37 in different hosts was carried out for detailed biochemical analysis (Wu et al. <xref ref-type="bibr" rid="CR51">2020</xref>). Among three <italic>Streptomyces</italic> hosts (<italic>S. lividans</italic> TK24, <italic>S. lividans</italic> 66 and <italic>S. albus</italic> J-1074), the <italic>S. lividans</italic> 66 recombinant variant gave the highest production of 4-FT while the least activity was found in <italic>S. lividans</italic> TK24 recombinant strain. The recombinant protein (FTaseMA) was purified to near homogeneity as a bright yellow protein with UV absorbance maxima at 335 and 425 nm, in which the enolimine peak at 325 nm is dominant. The stoichiometry between bound PLP and the protein was estimated to be 1:1. Incubation of the purified recombinant enzyme with <sc>l</sc>-Thr, FAd and PLP resulted in the production of 4-FT <bold>5</bold>, demonstrating that the recombinant protein is functional (Wu et al. <xref ref-type="bibr" rid="CR51">2020</xref>).</p><p id="Par16">FTases are unusual enzymes in that they use FAd <bold>17</bold> as a substrate, which is heavily hydrated in water as FAd hydrate <bold>17a</bold> (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>) (Cobb et al. <xref ref-type="bibr" rid="CR5">2004</xref>). As a result, the enzymes appear to evolve specific ability of accelerating the transformation of FAd hydrate <bold>17a</bold> to the aldehyde form <bold>17</bold> or FAd enol form <bold>17b</bold> for the next transaldolation reaction (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>). This is in line with the hybrid construction of functional FTases that have a small domain (A domain) homologous to aldolase/epimerase possibly involving the dehydrate reaction. Structural prediction of this A domain suggested good structural similarity with the metal-dependent class II aldolases (Wu et al. <xref ref-type="bibr" rid="CR51">2020</xref>). The active sites of these aldolases normally contain a catalytic tetrad of Glu-His-His-His, the latter three His residues of which coordinate a divalent metal acting as a Lewis acid type catalyst. The general mechanism of these aldolases involves the first Glu residue directing proton transfer of the aldol to generate an enediol intermediate, coordinated by the bound zinc. Examination of the predicted structure of the aldolase/epimerase domain of FTaseMA suggested a catalytic tetrad, Glu573-His551-His553-His598, with the essential residue of Asn484 that may position Glu573 residue towards the active site through hydrogen bonds. Indeed, elemental analysis of FTaseMA demonstrated that the stoichiometry of the bound zinc and the enzyme was estimated to be 1:1 (Wu et al. <xref ref-type="bibr" rid="CR51">2020</xref>). Alanine-scanning mutagenesis of the three His and Asn residues significantly reduced the production of 4-FT <bold>5</bold>, suggesting that these four residues are important (Wu et al. <xref ref-type="bibr" rid="CR51">2020</xref>). The mutated FTaseMA variant, in which Glu573 was changed to Ala, however, caused the instability of the purified protein for further biological evaluation.</p><p id="Par17">FTaseMA displays considerable substrate plasticity. Although FTaseMA cannot accept <sc>d</sc>-<italic>allo</italic>-threonine, <sc>d</sc>-threonine or glycine or alanine or leucine as substrates, consistent with the previous studies of FTase from <italic>S. cattleya</italic> (Murphy et al. <xref ref-type="bibr" rid="CR32">2001</xref>), it can use L-Ser as substrate, albeit with low conversion of 4-FT as monitored in <sup>19</sup>F-NMR. Most of the characterized LTTAs were found to accept L-Thr as the only retroaldol donor (Wu et al. <xref ref-type="bibr" rid="CR51">2020</xref>). Strikingly, the enzyme can also utilize L-<italic>allo</italic>-Thr as substrate with nine-fold less efficiency than the natural substrate <sc>l</sc>-Thr, a clear difference compared to other LTTAs. FTaseMA also accepts a range of electrophilic aldehyde acceptors with different functionalities, such as chloroacetaldehyde, glycolacetaldehyde, propanal, isobutyraldehyde, phenylacetaldehyde, when <sc>l</sc>-Thr was used, to generate different &#x003b2;HAAs, suggesting that this enzyme could be used as a potential versatile biocatalyst to produce various &#x003b2;HAAs (Wu et al. <xref ref-type="bibr" rid="CR51">2020</xref>). Of particular interests here is glycolacetaldehyde which is heavily hydrated in water. Seventy per cent of glycolacetaldehyde in the aqueous solutions exists as a diol form while only 4% is the aldehyde form (Collins and George <xref ref-type="bibr" rid="CR6">1971</xref>), further demonstrating the unusual ability of FTaseMA to dehydrate the diol of hydrated aldehyde species.</p></sec><sec id="Sec5"><title>LTTAs from the biosynthetic pathways of nucleoside antibiotic natural products</title><p id="Par18">Several lipopeptidyl nucleoside antibiotics, such as A-90289s <bold>8</bold> from <italic>Streptomyces</italic> sp. SANK 60405 (Fujita et al. <xref ref-type="bibr" rid="CR14">2011</xref>), and caprazamycins <bold>9</bold> from <italic>Streptomyces sp</italic>. MK730-62F (Igarashi et al. <xref ref-type="bibr" rid="CR22">2005</xref>), contain highly modified furanose motifs (Figs. <xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig4" ref-type="fig">4</xref>). Previous isotopic labelling studies suggested that a C&#x02013;C bond forming event, possibly via an aldol mechanism, occurs extending the carbon chain at C-5&#x02032; of the canonical nucleoside to C6 or longer chain length of a so-called high-carbon nucleoside scaffold (Winn et al. <xref ref-type="bibr" rid="CR48">2010</xref>).
<fig id="Fig4"><label>Fig. 4</label><caption><p>LipK and CapH are two LTTAs catalysing the transaldolation between <sc>l</sc>-Thr and uracil 5&#x02032;-aldehyde <bold>21</bold> in the biosynthetic pathways of lipopeptidyl nucleoside antibiotic natural products</p></caption><graphic xlink:href="253_2021_11288_Fig4_HTML" id="MO4"/></fig></p><p id="Par19">With the advance of genome sequencing technology in the last decade, the biosynthetic gene clusters (BGCs) of these nucleoside antibiotics have been identified for characterization (Barnard-Britson et al. <xref ref-type="bibr" rid="CR3">2012</xref>). Bioinformatics analysis of these clusters revealed that they shared an <italic>orf</italic>, putatively annotated as SHMT-like enzyme. This analysis was in line with the prediction of an aldol reaction that the putative SHMT ORFs may catalyse a biotransformation of Gly and nucleoside 5&#x02032;-aldehyde <bold>21</bold> to yield the corresponding high-carbon nucleoside intermediates during the biosynthesis of these antibiotics.</p><p id="Par20">Heterologous expression of <italic>lip</italic>K, encoding a putative SHMT in the BGC of A-90289s in <italic>S. lividan</italic> TK24, resulted in a soluble recombinant protein which contains a characteristic UV absorption maximum of 415 nm, corresponding to a typical <italic>holo</italic> PLP-dependent enzyme (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). This UV absorption was abolished in a LipK variant where Lys235 was changed to Ala, demonstrating that Lys235 is the key aa residue for the catalytic cycle (Barnard-Britson et al. <xref ref-type="bibr" rid="CR3">2012</xref>).</p><p id="Par21">Tests on the activity of LipK with <bold>21</bold> and Gly or other <sc>l</sc>-amino acids revealed that only incubation of <sc>l</sc>-Thr resulted in the appearance of a new compound as observed in HPLC analysis. The identity of the new compound was confirmed to be the &#x003b2;HAA containing glycine uracil <bold>22</bold> as evidenced by high-resolution MS and comprehensive 1D and 2D NMR analysis, in comparison to synthetic materials. The absolute stereochemistry of <bold>22</bold> was determined to be (5&#x02032;<italic>S</italic>, 6&#x02032;<italic>S</italic>) through the diagnostic <italic>J</italic> coupling value (<italic>J</italic><sub>H6&#x02032;-H5&#x02032;</sub> = 5.0 Hz) of the derivatised synthetic and enzymatic <bold>22</bold>. The enzyme displays restricted substrate specificity and only accepts <sc>l</sc>-Thr as the substrate. Unlike FTases, LipK is a single-domain LTTA. Further conserved genomic analysis indicated the occurrence of LipK homologues, suggesting that <sc>l</sc>-Thr transaldolation reaction may be more common than previously anticipated. LipK represents the second confirmed LTTA and the first subgroup of <sc>l</sc>-Thr:uridine-5&#x02032;-aldehyde (UA) transaldolase to catalyse the biotransformation of &#x003b2;HAA-containing nucleosides, providing a new biotechnological platform to prepare &#x003b2;HAA-containing sugar previously difficult to be synthesized.</p><p id="Par22">The second LipK-like LTTA, CapH, was identified in the BGC of capuramycin-type antibiotics A-500359s (Cai et al. <xref ref-type="bibr" rid="CR4">2015</xref>). Characterization of recombinant CapH revealed that CapH displays a similar biochemical property compared to LipK with restricted substrate specificity towards <sc>l</sc>-Thr. It has remained to be determined whether LipK or CapH utilises other nucleotide aldehydes except UA.</p></sec><sec id="Sec6"><title>LTTA from the pathway of &#x003b2;-lactone antibiotic</title><p id="Par23">The antibiotic natural product obafluorin <bold>2</bold> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) belongs to the chemical class of &#x003b2;-lactones, consisting of strained four-membered rings, closely related to &#x003b2;-lactam family of antibiotics, such as penicillin. Obafluorin <bold>2</bold> contains an interesting &#x003b2;HAA motif, (<italic>R</italic>)-&#x003b2;-hydroxy-<italic>p</italic>-nitro-<sc>l</sc>-homophenylalanine (&#x003b2;-OH-<italic>p</italic>-NO<sub>2</sub>-homoPhe) <bold>23</bold>. In 2017, the corresponding BGC (<italic>oba</italic>/<italic>obi</italic>) of obafluorine <bold>2</bold> was identified in the producer, <italic>Pseudomonas fluorescens</italic>, by two research groups simultaneously (Schaffer et al. <xref ref-type="bibr" rid="CR40">2017</xref>; Scott et al. <xref ref-type="bibr" rid="CR41">2017</xref>). Bioinformatics analysis suggested that one of the <italic>orf</italic>s in the BGC encodes a putative bacterial SHMT albeit low aa identity (25%). Overexpression of <italic>obi</italic>H (<italic>oba</italic>G) in <italic>E. coli</italic> resulted in the purification of the recombinant protein with unusual pink colour (Scott et al. <xref ref-type="bibr" rid="CR41">2017</xref>; Kumar et al. <xref ref-type="bibr" rid="CR24">2021</xref>). Biochemical assays coupled with isotopic labelling experiments demonstrated that ObiH (ObaG) is a new LTTA that catalyses the transaldolation between <sc>l</sc>-Thr and <italic>p</italic>-nitro-phenylacetaldehyde <bold>24</bold> to generate a single stereoisomer of &#x003b2;-OH-<italic>p</italic>-NO<sub>2</sub>-homoPhe with a yield of 55&#x02013;59% (Scott et al. <xref ref-type="bibr" rid="CR41">2017</xref>).</p><p id="Par24">ObiH (ObaG) displays a UV/Vis spectrum characteristic of PLP-dependent proteins, comprising absorption maxima at 340 nm and 390 nm that correspond to the internal ketoenamine <bold>10</bold> and enolimine <bold>10a</bold> (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>), respectively (Scott et al. <xref ref-type="bibr" rid="CR41">2017</xref>). The pink colour of ObiH attributing the UV absorption at 512 nm is correlated to the unusual internal quinonoid <bold>10b</bold> (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>), which is inactive state of the enzyme (Kumar et al. <xref ref-type="bibr" rid="CR24">2021</xref>). Exposing ObiH in the UV led to the rapid photoablation of the 515-nm peak and a temporary increase at 340 nm, followed by decrease of 340 nm band and increase of 415 nm band, indicative of an isomerization between the enolimine <bold>10a</bold> and ketoenamine <bold>10</bold> of the cofactor, respectively. Addition of <sc>l</sc>-Thr led to the formation of external glycyl quinonoid intermediate <bold>13</bold> that is remarkably persistent with a half-life of ~3 h, suggesting that ObiH catalyses the retro-aldol cleavage of <sc>l</sc>-Thr in the reaction cycle. The long lifetime of this glycyl quinonoid intermediate <bold>13</bold> would enable the enzyme reactivity with non-native aldehyde substrates for potential biocatalyst development.</p><p id="Par25">ObiH displays considerably good substrate promiscuity towards aldehyde acceptors, phenylacetaldehydes, various aliphatic and extended aryl aldehydes as well as a range of aromatic aldehydes (Kreitler et al. <xref ref-type="bibr" rid="CR23">2019</xref>). For example, incubation of phenylacetaldehyde with ObiH led to a single stereoisomer, (2<italic>S</italic>)-amino-(3<italic>R</italic>)-hydroxy-4-phenylbutanoate <bold>26a</bold>, while the reaction with benzaldehyde was less efficient leading to two products of <sc>l</sc>-<italic>threo</italic> and <sc>l</sc>-<italic>erythreo</italic>-phenylserine <bold>26b</bold> in a ratio of 1:2 and poor overall yield (&#x0003e;20%) (Fig. <xref rid="Fig5" ref-type="fig">5b</xref>) (Kreitler et al. <xref ref-type="bibr" rid="CR23">2019</xref>). Assay of an &#x003b1;-branched isobutyraldehyde with ObiH resulted in the production of a single stereoisomer, (2<italic>S</italic>,3<italic>R</italic>)-&#x003b2;-hydroxy-Leu <bold>26c</bold>, a &#x003b2;HAA that is difficult to be chemically constructed involving multiple methods (Fig. <xref rid="Fig5" ref-type="fig">5b</xref>) (Kreitler et al. <xref ref-type="bibr" rid="CR23">2019</xref>). These results suggested that ObiH and its homologues hold a potential for high diastereoselectivity depending on the substrate aldehydes for the synthesis of enantiomerically pure <sc>l</sc>-<italic>threo</italic>-&#x003b2;-hydroxy-&#x003b1;-amino acids.
<fig id="Fig5"><label>Fig. 5</label><caption><p><bold>a</bold> ObiH (ObaG) catalyses a transaldolation between <sc>l</sc>-Thr and <italic>p</italic>-nitro-phenylacetaldehyde <bold>24</bold> in the biosynthetic pathway of the &#x003b2;-lactone antibiotic natural product, obafluorine <bold>2</bold>. <bold>b</bold> ObiH displays considerable substrate flexibility towards various aryl and aliphatic aldehydes. <bold>c</bold> The structure of ObiH, the first structure of LTTA, indicating that ObiH forms a dimer (PDB access number: 7K34). Individual monomers are coloured in blue (chain A) and cyan (chain B). <bold>d</bold> The active site residues of ObiH are shown in sticks while the Lyn-bound PLP is shown in orange. Hydrogen bonds are shown as pink dashes. The active site of ObiH would allow targeted engineering approaches to further improve the efficiency of the transaldolation reactions catalysed by LTTAs in a broad context.</p></caption><graphic xlink:href="253_2021_11288_Fig5_HTML" id="MO5"/></fig></p><p id="Par26">The first crystal structure of LTTA was reported in 2021 (Kumar et al. <xref ref-type="bibr" rid="CR24">2021</xref>). ObiH (PDB number: 7K34) crystallized as a homodimer (Fig. <xref rid="Fig5" ref-type="fig">5c</xref>), with an extension of the C-terminus forming the dimer interface, consistent with other members of the fold-type I superfamily of PLP-dependent enzymes (Eliot and Kirsch <xref ref-type="bibr" rid="CR12">2004</xref>). The ObiH active site lies at the dimer interface, with most of the key residues contributed from a single unit (Kumar et al. <xref ref-type="bibr" rid="CR24">2021</xref>). Sequence alignment with other LTTAs and SHMTs and structural information revealed that Lys234, Arg366, His131, Tyr55 and Asp204 in the case of ObiH (Fig. <xref rid="Fig5" ref-type="fig">5d</xref>) are highly conserved and are in the close proximity of the PLP cofactor in the active site (Kumar et al. <xref ref-type="bibr" rid="CR24">2021</xref>). The pyridine ring of PLP is stacked with His 131, and the PLP phosphate is buried with extended H-bond networks, including two to Tyr55 and Asn268 from the partner subunit. Asp204 forms hydrogen bonds to the pyridine nitrogen of PLP, thereby increasing the electrophilicity of pyridinium moiety. Mutational analysis indicated that Asp204 is essential for the catalysis (Kumar et al. <xref ref-type="bibr" rid="CR24">2021</xref>).</p></sec><sec id="Sec7"><title>LTTA from the biosynthetic pathway of thioheptose nucleoside antibiotic natural products</title><p id="Par27">Albomycins <bold>7</bold> are sulphur-containing sideromycin antibiotics, which have intriguing structures consisting of a 6&#x02032;-amino-4&#x02032;-thioheptose nucleoside <bold>27</bold> and an iron-chelating ferrichrome siderophore that are linked via amide linkage to an <sc>l</sc>-Ser residue (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). Unlike lipopeptidyl nucleoside antibiotics such as A90289s that contain <sc>d</sc>-ribose and <sc>l</sc>-amino acid residues in the high-carbon nucleoside scaffold, albomycins has the <sc>d</sc>-configuration (6&#x02032;<italic>R</italic>) of the &#x003b1;-amino acid and the <sc>d</sc>-<italic>xylo</italic>-configuration (3&#x02032;<italic>R</italic>) of the furanose ring in the thioheptose core which is rare occurrence found in nature. Bioinformatics analysis suggested that the corresponding BGC of albomycins contain an <italic>orf</italic> (<italic>amb</italic>H), the gene product of which encodes an LTTA-like enzyme that was proposed to catalyse the transaldol reaction of <sc>l</sc>-Thr and 5&#x02032;-oxo-4&#x02032;-thioxylofuranose nucleoside <bold>27</bold> to form the C&#x02032;5-C&#x02032;6 bond in <bold>28</bold> (Fig. <xref rid="Fig6" ref-type="fig">6a</xref>).
<fig id="Fig6"><label>Fig. 6</label><caption><p>AbmH catalyses the transaldolation reaction between <sc>l</sc>-Thr and a very unusual thioribofuranose aldehyde substrate, followed by two epimerization events catalysed by a radical SAM AmbJ and PLP-dependent epimerase AmbD to finally install the thiopentose moiety in albomycins</p></caption><graphic xlink:href="253_2021_11288_Fig6_HTML" id="MO6"/></fig></p><p id="Par28">However, biochemical analysis demonstrated that 5&#x02032;-oxo-<sc>d</sc>-thioribose nucleoside <bold>29</bold> is the <italic>bona fide</italic> substrate of recombinant AmbH (Ushimaru and Liu <xref ref-type="bibr" rid="CR46">2019</xref>). AmbH catalyses a regio- and stereo-selective transaldol reaction between <sc>l</sc>-Thr and <bold>29</bold> to yield the thioheptose core with a <sc>d</sc>-ribofuranose ring and an <sc>l</sc>-amino acid moiety <bold>30</bold>, followed by the epimerization of the <sc>l</sc>-amino acid to generate <sc>d</sc>-amino acid catalysed by another PLP-dependent racemerase/epimerase AmbD to provide <bold>28c</bold>. The <sc>d</sc>-thioribose ring to <sc>d</sc>-xylofuranose counterpart <bold>28a</bold> is likely to be mediated by the radical SAM epimerase AmbJ based on the gene deletion and complementation experiments (Fig. <xref rid="Fig6" ref-type="fig">6b</xref>). The latter two epimerization events catalysed by AmbD and AmbJ appear to be essential for conferring the antimicrobial activity of albomycins despite no major structural alterations (Ushimaru and Liu <xref ref-type="bibr" rid="CR46">2019</xref>). AmbH displays considerable substrate plasticity toward 3&#x02032;<italic>R</italic>-epimer of <bold>29</bold>, <sc>d</sc>-xylose-based nucleoside aldehyde <bold>27</bold> (Fig. <xref rid="Fig6" ref-type="fig">6a</xref>), but the enzymatic products lost stereoselectivity, providing a mixture of stereoisomers (Ushimaru and Liu <xref ref-type="bibr" rid="CR46">2019</xref>). The insertion of a sulphur atom into the <sc>d</sc>-ribofuranose ring during the biosynthesis of albomycins has remained to be determined.</p></sec></sec><sec id="Sec8"><title>Discovery of LTTA homologue as biocatalysts</title><p id="Par29">The discovery of the single-domain LTTAs in the biosynthesis of natural products facilitates a conserved genomic approach with the aim of identifying new LTTA homologues. Given the importance of &#x003b2;HAAs and difficulty of constructing enantiomer of &#x003b2;HAAs, there has been a considerable attraction to utilising LTTA homologues as biocatalysts to provide a single-step synthesis of &#x003b2;HAAs under the mild conditions with high stereoselectivity.</p><p id="Par30">This is the case of PsLTTA from a <italic>Pseudomonas</italic> strain, which has 99% sequence identity to ObiH (Xu et al. <xref ref-type="bibr" rid="CR53">2019</xref>). Biochemical analysis demonstrated that PsLTTA accepts <sc>l</sc>-Thr as the donor substrate among Thr isomers but consumes a wide range of aromatic aldehydes with various substituents in <italic>o</italic>, <italic>p</italic>, <italic>m</italic> position in the aromatic ring as acceptors (Fig. <xref rid="Fig7" ref-type="fig">7</xref>). Among these aldehyde acceptors, PsLTTA is able to mediate <italic>p</italic>-methylsulfonyl-benzaldehyde <bold>31b</bold> and <sc>l</sc>-Thr to produce <sc>l</sc>-<italic>threo</italic>-<italic>p</italic>-methylsulfonylphenylserine <bold>32</bold> with a high conversion rate and a high de value. It is worth noting that <bold>32</bold> is the key intermediate for synthesis of thiamphenicol and florfenicol. In an optimised condition, the whole cell containing overexpressed recombinant PsLTTA provided an excellent conversion of 67.1% with almost perfect stereoselective ratio of 94.5%. Synthesis of <bold>32</bold> was also conducted in a 100-mL scale of whole-cell biotransformation, first demonstrating that PsLTTA could be utilised as a robust biocatalyst for one-step preparation of &#x003b2;HAAs.
<fig id="Fig7"><label>Fig. 7</label><caption><p>A ObiH homologue, PsLTTA, catalyses a promiscuous transaldolation to generate various phenylserine derivatives</p></caption><graphic xlink:href="253_2021_11288_Fig7_HTML" id="MO7"/></fig></p></sec><sec id="Sec9"><title>Directed evolution of mutated LTTA homologue with enhanced capacity</title><p id="Par31">One-step stereoselective enzymatic synthesis of &#x003b2;HAAs has already attracted a considerable attention as this method offers better atomic economy under mild conditions with few by-products generated compared to chemical synthesis. Although PsLTTA showed the potential to catalyse the asymmetric synthesis of <bold>32</bold>, the overall productivity was moderate, preventing the enzyme to be used as viable biocatalysts.</p><p id="Par32">There are two factors that influence the catalytic efficiency. Firstly, PsLTTA catalyses a reversible reaction depending on the concentrations of substrates and products. The accumulation of acetaldehyde may inhibit the forward transaldolation reaction. Secondly, the aldehyde donors are not the natural substrate of PsLTTA, resulting in low conversion and possibly less stereoselectivity. Therefore, it would be desirable to create an enzymatic system that consists of an engineered PsLTTA with an improved activity towards aldehyde acceptors and other enzymes to eliminate the accumulation of acetaldehyde.</p><p id="Par33">Directed evolution has been proven to be a powerful method for improving biocatalyst&#x02019;s activities (Packer and Liu <xref ref-type="bibr" rid="CR36">2015</xref>). The key to apply directed evolution is to develop a high throughput screening (HTS) method (Ye et al. <xref ref-type="bibr" rid="CR54">2018</xref>). To this end, Xu et al. developed a coupled enzymatic reaction that can be used as the HTS (Xu et al. <xref ref-type="bibr" rid="CR52">2020</xref>). Firstly, they applied error-prone PCR method. Overexpression of PCR-mutated genes in <italic>E. coli</italic> and the whole-cell assays in 96-well plate with the reaction cocktail including PLP, aldehyde acceptor and <sc>l</sc>-Thr were carried out. In the reaction supernatants, alcohol dehydrogenase from <italic>Acetobacter pasteurianus</italic> (ApADH) was added to transform acetaldehyde to ethanol and convert NADH to NAD<sup>+</sup>, the latter activity of which can be assessed by monitoring the reduction of NADH at 340 nm (Fig. <xref rid="Fig8" ref-type="fig">8</xref>). More than 4000 colonies were screened. As a result, the double-point PsLTTA variant (PsLLTTAM2) where Asn35 and Cys57 were changed to Ser and Asn, respectively, was found to have the maximal enhanced production of the target &#x003b2;HAA with about 2.1-fold increase compared to wild-type PsLTTA in the whole-cell assays. Subsequently, PsLLTTAM2 was purified for biochemical characterization. The apparent catalytic efficiency (<italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>m</sub>) of PsLLTTAM2 was 7.2-fold higher than the one for wild-type PsLLTTA. It is worth noting that such two mutations in PsLLTTA are consistent with the assessment of the structure of ObiH (Kumar et al. <xref ref-type="bibr" rid="CR24">2021</xref>) that Asn35 is in the active site of the enzyme and that Cys57 is within a highly mobile loop.
<fig id="Fig8"><label>Fig. 8</label><caption><p>Directed evolution and high throughput screening development enable the discovery of a PsLTTA variant with higher enantioselectivity and productivity, followed by synthetic biology approach to create an engineered <italic>E. coli</italic> chassis for &#x003b2;HAA production.</p></caption><graphic xlink:href="253_2021_11288_Fig8_HTML" id="MO8"/></fig></p><p id="Par34">To further improve the yield of &#x003b2;HAA produced by PsLLTTAM2, Xu et al (Xu et al. <xref ref-type="bibr" rid="CR52">2020</xref>) developed a regeneration cycle of NADH coupling with the third enzyme, formate dehydrogenase from <italic>Candida boidinii</italic> (CbFDH), to convert NAD<sup>+</sup> back to NADH using formic acid as substrate (Fig. <xref rid="Fig8" ref-type="fig">8</xref>). Such an acetaldehyde elimination system significantly improved the titre of <bold>32</bold> by 4-fold (61.3 mM) compared to the one without the acetaldehyde elimination system in the whole-cell studies (Xu et al. <xref ref-type="bibr" rid="CR52">2020</xref>). Finally, an engineered <italic>E. coli</italic> chassis was generated, which contains three genes, <italic>psLLTTAM2</italic>, <italic>cbFDH</italic> and <italic>apADH</italic>. The titre of <bold>32</bold> from this engineered strain was further up to 101.7 mM, 8.8-fold increase compared to the single system of PsLLTTA. The benefit for this synthetic biology approach is that the biotransformation generates ethanol as the by-product. However, the high concentration of accumulated ethanol may inhibit the growth of this engineered <italic>E. coli</italic>, resulting in low productivity of &#x003b2;HAAs in turn in the industrial setting. Therefore, it may be worthy considering using other microbial chassis with high tolerance of ethanol production in the future development.</p></sec><sec id="Sec10"><title>Conclusion and future perspectives</title><p id="Par35">Although the first LTTA was discovered almost two decades ago, the catalytic potential of this group of enzymes was only assessed during the last decade, coincident with the advanced genome sequencing technology. Much is still needed to expand the scope of LTTA biocatalysts for asymmetric synthesis of industrially important &#x003b2;HAAs. It is exciting to fully use the existing enzyme inventory to accommodate new chemistries for biotechnologically viable &#x003b2;HAA synthesis. Within this limited pool of identified enzymes, some LTTAs display great substrate flexibility toward aldehyde acceptors with considerably good stereoselectivity. However, the overall productivity of the &#x003b2;HAAs is not yet desirable as a viable biocatalyst. As a complement to this, we should also turn our attention to protein engineering to enhance the activities of the promising enzyme candidates. This was exemplified by the recent HTS method which has set a framework for directed evolution of LTTAs (Fig. <xref rid="Fig8" ref-type="fig">8</xref>).</p><p id="Par36">Another potential exciting development is to turn our attention to nature for inspirations by discovering new &#x003b2;HAA-containing entities through natural product programmes and new LTTAs with broad substrate specificity, better kinetics, high regio- and stereo-selectivity and good tolerance towards reaction conditions (i.e. organic solvents, temperatures) by genomic mining strategy (Fig. <xref rid="Fig8" ref-type="fig">8</xref>). It should be noted that the majority of LTTAs was identified from two bacterial species, <italic>actinomycetes</italic> and <italic>pseudomonas</italic>, in the current enzyme inventory. Protein motif analysis (Bailey et al. <xref ref-type="bibr" rid="CR2">2009</xref>) combined with the available structure data of ObiH (Kumar et al. <xref ref-type="bibr" rid="CR24">2021</xref>) suggested that LTTAs contain unique conserved motifs, including F58, W68 and F70 in the mobile loop of ObiH, and H324 and Q325 which form extensive hydrogen bond network with the residues, H207 and R366, in the active site of ObiH (Fig. <xref rid="Fig9" ref-type="fig">9</xref>). This information could serve as guidance for future LTTA mining. Therefore, efforts directed towards LTTA candidates from other microbial genus will certainly offer a promising opportunity of discovering a biotechnologically viable biocatalyst for &#x003b2;HAA synthesis.
<fig id="Fig9"><label>Fig. 9</label><caption><p><bold>a</bold> Protein motif analysis suggested that LTTAs contain two unique aa motifs compared to <italic>E. coli</italic> SHMT enzyme. Some of aa residues are highly conserved among LTTAs. <bold>b</bold> The hydrogen bond network formed among H324 and Q325 with the residues, H207 and R366, in the active site of ObiH is shown as pink dashes. Lys-bound PLP is shown in orange</p></caption><graphic xlink:href="253_2021_11288_Fig9_HTML" id="MO9"/></fig></p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contribution</title><p>S.W. and H.D. wrote the review and have contributed equally to this work. S.W. and H.D. edited this review. S.W. and H.D. designed the structure and revised this review.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was funded by Biotechnology and Biological Sciences Research Council UK (BBSRC) (BB/P00380X/1, BB/R00479X/1 and BB/R50547X/1), Scottish Funding Council COVID-19 Grant extension and Bridging Fund, and Industrial Biotechnology Innovation Centre (IBioIC, Scotland).</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethical statement</title><p id="Par37">This article does not contain any studies with animals performed by any of the authors.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par38">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashford</surname><given-names>PA</given-names></name><name><surname>Bew</surname><given-names>SP</given-names></name></person-group><article-title>Recent advances in the synthesis of new glycopeptide antibiotics</article-title><source>Chem Soc Rev</source><year>2012</year><volume>41</volume><fpage>957</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1039/c1cs15125h</pub-id><?supplied-pmid 21829829?><pub-id pub-id-type="pmid">21829829</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>TL</given-names></name><name><surname>Boden</surname><given-names>M</given-names></name><name><surname>Buske</surname><given-names>FA</given-names></name><name><surname>Frith</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>CE</given-names></name><name><surname>Clementi</surname><given-names>L</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>WW</given-names></name><name><surname>Noble</surname><given-names>WS</given-names></name></person-group><article-title>MEME Suite: tools for motif discovery and searching</article-title><source>Nucleic Acids Res</source><year>2009</year><volume>37</volume><fpage>W202</fpage><lpage>W208</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp335</pub-id><?supplied-pmid 19458158?><pub-id pub-id-type="pmid">19458158</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnard-Britson</surname><given-names>S</given-names></name><name><surname>Chi</surname><given-names>X</given-names></name><name><surname>Nonaka</surname><given-names>K</given-names></name><name><surname>Spork</surname><given-names>AP</given-names></name><name><surname>Tibrewal</surname><given-names>N</given-names></name><name><surname>Goswami</surname><given-names>A</given-names></name><name><surname>Pahari</surname><given-names>P</given-names></name><name><surname>Ducho</surname><given-names>C</given-names></name><name><surname>Rohr</surname><given-names>J</given-names></name><name><surname>Van Lanen</surname><given-names>SG</given-names></name></person-group><article-title>Amalgamation of nucleosides and amino acids in antibiotic biosynthesis: discovery of an L-threonine: uridine-5&#x02032;-aldehyde transaldolase</article-title><source>J Am Chem Soc</source><year>2012</year><volume>134</volume><fpage>18514</fpage><lpage>18517</lpage><pub-id pub-id-type="doi">10.1021/ja308185q</pub-id><?supplied-pmid 23110675?><pub-id pub-id-type="pmid">23110675</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>W</given-names></name><name><surname>Goswami</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Green</surname><given-names>KD</given-names></name><name><surname>Barnard-Britson</surname><given-names>S</given-names></name><name><surname>Baba</surname><given-names>S</given-names></name><name><surname>Funabashi</surname><given-names>M</given-names></name><name><surname>Nonaka</surname><given-names>K</given-names></name><name><surname>Sunkara</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>AJ</given-names></name><name><surname>Spork</surname><given-names>AP</given-names></name><name><surname>Ducho</surname><given-names>C</given-names></name><name><surname>Garneau-Tsodikova</surname><given-names>S</given-names></name><name><surname>Thorson</surname><given-names>JS</given-names></name><name><surname>Van Lanen</surname><given-names>SG</given-names></name></person-group><article-title>The biosynthesis of capuramycin-type antibiotics: identification of the A-102395 biosynthetic gene cluster, mechanism of self-resistance, and formation of uridine-5&#x02032;-carboxamide</article-title><source>J Biol Chem</source><year>2015</year><volume>290</volume><fpage>13710</fpage><lpage>13724</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.646414</pub-id><?supplied-pmid 25855790?><pub-id pub-id-type="pmid">25855790</pub-id></element-citation></ref><ref id="CR5"><mixed-citation publication-type="other">Cobb SL, Deng H, Hamilton JTG, McGlinchey RP, O&#x02019;Hagan D (2004) Identification of 5-fluoro-5-deoxy-D-ribose-1-phosphate as an intermediate in fluorometabolite biosynthesis in <italic>Streptomyces cattleya</italic>. Chem Commun:592&#x02013;593. 10.1039/B400754A</mixed-citation></ref><ref id="CR6"><mixed-citation publication-type="other">Collins GCS, George WO (1971) Nuclear magnetic resonance spectra of glycolaldehyde. J Chem Soc B Phys Org:1352&#x02013;1355. 10.1039/J29710001352</mixed-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Cross</surname><given-names>SM</given-names></name><name><surname>McGlinchey</surname><given-names>RP</given-names></name><name><surname>Hamilton</surname><given-names>JTG</given-names></name><name><surname>O&#x02019;Hagan</surname><given-names>D</given-names></name></person-group><article-title>In vitro reconstituted biotransformation of 4-fluorothreonine from fluoride ion: application of the fluorinase</article-title><source>Chem Biol</source><year>2008</year><volume>15</volume><fpage>1268</fpage><lpage>1276</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2008.10.012</pub-id><?supplied-pmid 19101471?><pub-id pub-id-type="pmid">19101471</pub-id></element-citation></ref><ref id="CR8"><mixed-citation publication-type="other">Deng H, Ma L, Bandaranayaka N, Qin Z, Mann G, Kyeremeh K, Yu Y, Shepherd T, Naismith JH, O&#x02019;Hagan D (2014) Identification of fluorinases from <italic>Streptomyces</italic> sp MA37, <italic>Norcardia brasiliensis</italic>, and <italic>Actinoplanes</italic> sp N902-109 by genome mining. ChemBioChem 15:364&#x02013;368. 10.1002/cbic.201300732</mixed-citation></ref><ref id="CR9"><mixed-citation publication-type="other">Deng H, O&#x02019;Hagan D, Schaffrath C (2004) Fluorometabolite biosynthesis and the fluorinase from <italic>Streptomyces cattleya</italic>. Nat Prod Rep 21:773&#x02013;784. 10.1039/B415087M</mixed-citation></ref><ref id="CR10"><mixed-citation publication-type="other">Dong C, Huang F, Deng H, Schaffrath C (2004) Crystal structure and mechanism of a bacterial fluorinating enzyme. Nature. 427:561&#x02013;565. 10.1038/nature02303.1</mixed-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Ryan</surname><given-names>KS</given-names></name></person-group><article-title>Pyridoxal phosphate-dependent reactions in the biosynthesis of natural products</article-title><source>Nat Prod Rep</source><year>2019</year><volume>36</volume><fpage>430</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1039/c8np00049b</pub-id><?supplied-pmid 30183796?><pub-id pub-id-type="pmid">30183796</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eliot</surname><given-names>AC</given-names></name><name><surname>Kirsch</surname><given-names>JF</given-names></name></person-group><article-title>Pyridoxal phosphate enzymes: mechanistic, structural, and evolutionary considerations</article-title><source>Annu Rev Biochem</source><year>2004</year><volume>73</volume><fpage>383</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.73.011303.074021</pub-id><?supplied-pmid 15189147?><pub-id pub-id-type="pmid">15189147</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fesko</surname><given-names>K</given-names></name></person-group><article-title>Threonine aldolases: perspectives in engineering and screening the enzymes with enhanced substrate and stereo specificities</article-title><source>Appl Microbiol Biotechnol</source><year>2016</year><volume>100</volume><fpage>2579</fpage><lpage>2590</lpage><pub-id pub-id-type="doi">10.1007/s00253-015-7218-5</pub-id><?supplied-pmid 26810201?><pub-id pub-id-type="pmid">26810201</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>Y</given-names></name><name><surname>Kizuka</surname><given-names>M</given-names></name><name><surname>Funabashi</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>Y</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Nonaka</surname><given-names>K</given-names></name><name><surname>Takatsu</surname><given-names>T</given-names></name></person-group><article-title>A-90289 A and B, new inhibitors of bacterial translocase I, produced by <italic>Streptomyces</italic> sp. SANK 60405</article-title><source>J Antibiot (Tokyo)</source><year>2011</year><volume>64</volume><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1038/ja.2011.38</pub-id><pub-id pub-id-type="pmid">21587261</pub-id></element-citation></ref><ref id="CR15"><mixed-citation publication-type="other">Hamilton JTG, Amin MR, Harper B, Hagan DO, Spx BT (1997) Biosynthesis of fluoroacetate and 4-fluorothreonine by <italic>Streptomyces cattleya</italic>. Glycine and pyruvate as precursors. Chem Commun:797&#x02013;798. 10.1039/A700495H</mixed-citation></ref><ref id="CR16"><mixed-citation publication-type="other">Hamilton JTG, Murphy CD, Amin MR, Hagan DO, Harper DB (1998) Exploring the biosynthetic origin of fluoroacetate and 4- fluorothreonine in <italic>Streptomyces cattleya</italic>. Chem Commun:759&#x02013;767. 10.1039/A706554J</mixed-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauser</surname><given-names>RA</given-names></name><name><surname>Heritier</surname><given-names>S</given-names></name><name><surname>Rowse</surname><given-names>GJ</given-names></name><name><surname>Hewitt</surname><given-names>LA</given-names></name><name><surname>Isaacson</surname><given-names>SH</given-names></name></person-group><article-title>Droxidopa and reduced falls in a trial of Parkinson disease patients with neurogenic orthostatic hypotension</article-title><source>Clin Neuropharmacol</source><year>2016</year><volume>39</volume><fpage>220</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1097/WNF.0000000000000168</pub-id><?supplied-pmid 27332626?><pub-id pub-id-type="pmid">27332626</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hibi</surname><given-names>M</given-names></name><name><surname>Kasahara</surname><given-names>T</given-names></name><name><surname>Kawashima</surname><given-names>T</given-names></name><name><surname>Yajima</surname><given-names>H</given-names></name><name><surname>Kozono</surname><given-names>S</given-names></name><name><surname>Smirnov</surname><given-names>SV</given-names></name><name><surname>Kodera</surname><given-names>T</given-names></name><name><surname>Sugiyama</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Yokozeki</surname><given-names>K</given-names></name><name><surname>Ogawa</surname><given-names>J</given-names></name></person-group><article-title>Multi-enzymatic synthesis of optically pure &#x003b2;-hydroxy &#x003b1;-amino acids</article-title><source>Adv Synth Catal</source><year>2015</year><volume>357</volume><fpage>767</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1002/adsc.201400672</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>F</given-names></name><name><surname>Haydock</surname><given-names>SF</given-names></name><name><surname>Spiteller</surname><given-names>D</given-names></name><name><surname>Mironenko</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Hagan</surname><given-names>DO</given-names></name><name><surname>Leadlay</surname><given-names>PF</given-names></name><name><surname>Spencer</surname><given-names>JB</given-names></name></person-group><article-title>The gene cluster for fluorometabolite biosynthesis in <italic>Streptomyces cattleya</italic>: a thioesterase confers resistance to fluoroacetyl-coenzyme A</article-title><source>Chem Biol</source><year>2006</year><volume>13</volume><fpage>475</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2006.02.014</pub-id><?supplied-pmid 16720268?><pub-id pub-id-type="pmid">16720268</pub-id></element-citation></ref><ref id="CR20"><mixed-citation publication-type="other">Huang S, Ma L, Tong MH, Yu Y, O&#x02019;Hagan D, Deng H (2014) Fluoroacetate biosynthesis from the marine-derived bacterium <italic>Streptomyces xinghaiensis</italic> NRRL B-24674. Org Biomol Chem:4828&#x02013;4831. 10.1039/c4ob00970c</mixed-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000fc;ttel</surname><given-names>W</given-names></name></person-group><article-title>Echinocandins: structural diversity, biosynthesis, and development of antimycotics</article-title><source>Appl Microbiol Biotechnol</source><year>2021</year><volume>105</volume><fpage>55</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1007/s00253-020-11022-y</pub-id><?supplied-pmid 33270153?><pub-id pub-id-type="pmid">33270153</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igarashi</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Shitara</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Naganawa</surname><given-names>H</given-names></name><name><surname>Miyake</surname><given-names>T</given-names></name><name><surname>Akamatsu</surname><given-names>Y</given-names></name></person-group><article-title>Caprazamycins, novel Lipo-nucleoside antibiotics, from <italic>Streptomyces</italic> sp</article-title><source>J Antibiot (Tokyo)</source><year>2005</year><volume>58</volume><fpage>327</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1038/ja.2005.41</pub-id><pub-id pub-id-type="pmid">16060385</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreitler</surname><given-names>DF</given-names></name><name><surname>Gemmell</surname><given-names>EM</given-names></name><name><surname>Schaffer</surname><given-names>JE</given-names></name><name><surname>Wencewicz</surname><given-names>TA</given-names></name><name><surname>Gulick</surname><given-names>AM</given-names></name></person-group><article-title>The structural basis of N-acyl-&#x003b1;-amino-&#x003b2;-lactone formation catalyzed by a nonribosomal peptide synthetase</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/s41467-019-11383-7</pub-id><pub-id pub-id-type="pmid">30602773</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Meza</surname><given-names>A</given-names></name><name><surname>Ellis</surname><given-names>JM</given-names></name><name><surname>Carlson</surname><given-names>GA</given-names></name><name><surname>Bingman</surname><given-names>CA</given-names></name><name><surname>Buller</surname><given-names>AR</given-names></name></person-group><article-title>L-threonine transaldolase activity is enabled by a persistent catalytic intermediate</article-title><source>ACS Chem Biol</source><year>2021</year><volume>16</volume><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1021/acschembio.0c00753</pub-id><?supplied-pmid 33337128?><pub-id pub-id-type="pmid">33337128</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levitskiy</surname><given-names>OA</given-names></name><name><surname>Grishin</surname><given-names>YK</given-names></name><name><surname>Magdesieva</surname><given-names>TV</given-names></name></person-group><article-title>Stereoselective electrosynthesis of -hydroxy- &#x003b1; -amino acids in the form of Ni II -Schiff-base complexes</article-title><source>Eur J Org Chem</source><year>2019</year><volume>3174&#x02013;3182</volume><fpage>3174</fpage><lpage>3182</lpage><pub-id pub-id-type="doi">10.1002/ejoc.201900466</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name></person-group><article-title>New stereoselective synthesis of thiamphenicol and florfenicol from enantiomerically pure cyanohydrin: a chemo-enzymatic approach</article-title><source>Tetrahedron</source><year>2008</year><volume>64</volume><fpage>7822</fpage><lpage>7827</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2008.05.113</pub-id></element-citation></ref><ref id="CR27"><mixed-citation publication-type="other">Ma L, Bartholome A, Tong MH, Qin Z, Yu Y, Shepherd T, Kyeremeh K, Deng H, O&#x02019;Hagan D (2015) Identification of a fluorometabolite from <italic>Streptomyce</italic>s sp. MA37: (2R3S4S)-5-fluoro-2,3,4-trihydroxypentanoic acid. Chem Sci:1414&#x02013;1419. 10.1039/c4sc03540b</mixed-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>W</given-names></name><name><surname>Naoi</surname><given-names>M</given-names></name><name><surname>Narabayashi</surname><given-names>H</given-names></name></person-group><article-title>The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients</article-title><source>J Neurol Sci</source><year>1996</year><volume>139</volume><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/0022-510X(96)00049-4</pub-id><?supplied-pmid 8836986?><pub-id pub-id-type="pmid">8836986</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masruri</surname></name><name><surname>Willis</surname><given-names>AC</given-names></name><name><surname>McLeod</surname><given-names>MD</given-names></name></person-group><article-title>Osmium-catalyzed vicinal oxyamination of alkenes by N-(4- toluenesulfonyloxy) carbamates</article-title><source>J Organomet Chem</source><year>2012</year><volume>77</volume><fpage>8480</fpage><lpage>8491</lpage><pub-id pub-id-type="doi">10.1021/jo301372y</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>IS</given-names></name><name><surname>Amorim</surname><given-names>CL</given-names></name><name><surname>Murphy</surname><given-names>CD</given-names></name><name><surname>Castro</surname><given-names>PML</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Prasad</surname></name><name><surname>Aranda</surname></name></person-group><article-title>Strategies for biodegreadation of fluorinated compounds</article-title><source>Approaches in Bioremediation</source><year>2018</year><publisher-loc>Cham</publisher-loc><publisher-name>Springer</publisher-name><fpage>239</fpage><lpage>280</lpage></element-citation></ref><ref id="CR31"><mixed-citation publication-type="other">Moss SJ, Murphy CD, Hamilton JTG, Mcroberts WC, Hagan DO, Schaffrath C, Harper DB (2000) Fluoroacetaldehyde: a precursor of both fluoroacetate and 4-fluorothreonine in <italic>Streptomyces cattleya</italic>. Chem Commun:2281&#x02013;2282. 10.1039/b007261n</mixed-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>CD</given-names></name><name><surname>O&#x02019;Hagan</surname><given-names>D</given-names></name><name><surname>Schaffrath</surname><given-names>C</given-names></name></person-group><article-title>Identification of a PLP-dependent threonine transaldolase: a novel enzyme involved in 4-fluorothreonine biosynthesis in <italic>Streptomyces cattleya</italic></article-title><source>Angew Chem Int Ed</source><year>2001</year><volume>40</volume><fpage>4479</fpage><lpage>4481</lpage><pub-id pub-id-type="doi">10.1002/1521-3773(20011203)40:23&#x0003c;4479::AID-ANIE4479&#x0003e;3.0.CO;2-1</pub-id></element-citation></ref><ref id="CR33"><mixed-citation publication-type="other">Nieschalk J, Hamilton JTG, Murphy CD, Harper B, Hagan DO (1997) Biosynthesis of fluoroacetate and 4-fluorothreonine by <italic>Streptomyces cattleya</italic>. The stereochemical processing of glycerol. Chem Commun:799&#x02013;800. 10.1039/A700498B</mixed-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Hagan</surname><given-names>D</given-names></name><name><surname>Deng</surname><given-names>H</given-names></name></person-group><article-title>Enzymatic fluorination and biotechnological developments of the fluorinase</article-title><source>Chem Rev</source><year>2015</year><volume>115</volume><fpage>634</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1021/cr500209t</pub-id><?supplied-pmid 25253234?><pub-id pub-id-type="pmid">25253234</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Hagan</surname><given-names>D</given-names></name><name><surname>Schaffrath</surname><given-names>C</given-names></name><name><surname>Cobb</surname><given-names>SL</given-names></name><name><surname>Hamilton</surname><given-names>JTG</given-names></name></person-group><article-title>Biosynthesis of an organofluorine molecule</article-title><source>Nature.</source><year>2002</year><volume>416</volume><fpage>279</fpage><pub-id pub-id-type="doi">10.1038/416279a</pub-id><?supplied-pmid 11907567?><pub-id pub-id-type="pmid">11907567</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Packer</surname><given-names>MS</given-names></name><name><surname>Liu</surname><given-names>DR</given-names></name></person-group><article-title>Methods for the directed evolution of proteins</article-title><source>Nat Rev Genet</source><year>2015</year><volume>16</volume><fpage>379</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1038/nrg3927</pub-id><?supplied-pmid 26055155?><pub-id pub-id-type="pmid">26055155</pub-id></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>JP</given-names></name><name><surname>Amyes</surname><given-names>TL</given-names></name><name><surname>Crugeiras</surname><given-names>J</given-names></name><name><surname>Rios</surname><given-names>A</given-names></name></person-group><article-title>Pyridoxal 5&#x02019;-phosphate: electrophilic catalyst extraordinaire</article-title><source>Curr Opin Chem Biol</source><year>2009</year><volume>13</volume><issue>4</issue><fpage>475</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2009.06.023</pub-id><?supplied-pmid 19640775?><pub-id pub-id-type="pmid">19640775</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samland</surname><given-names>AK</given-names></name><name><surname>Rale</surname><given-names>M</given-names></name><name><surname>Sprenger</surname><given-names>GA</given-names></name><name><surname>Fessner</surname><given-names>W</given-names></name></person-group><article-title>The transaldolase family: new synthetic opportunities from an ancient enzyme scaffold</article-title><source>ChemBioChem.</source><year>2011</year><volume>12</volume><fpage>1454</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.1002/cbic.201100072</pub-id><?supplied-pmid 21574238?><pub-id pub-id-type="pmid">21574238</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanada</surname><given-names>M</given-names></name><name><surname>Miyano</surname><given-names>T</given-names></name><name><surname>Iwadare</surname><given-names>S</given-names></name><name><surname>Williamson</surname><given-names>JM</given-names></name><name><surname>Arison</surname><given-names>BH</given-names></name><name><surname>Smith</surname><given-names>JL</given-names></name><name><surname>Douglas</surname><given-names>AW</given-names></name><name><surname>Liesch</surname><given-names>JM</given-names></name><name><surname>Inamine</surname><given-names>E</given-names></name></person-group><article-title>Biosynthesis of fluorothreonine and fluoroacetic acid by the thienamycin producer, <italic>Streptomyces cattleya</italic></article-title><source>J Antibiot (Tokyo)</source><year>1986</year><volume>39</volume><fpage>259</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.39.259</pub-id><pub-id pub-id-type="pmid">3082840</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffer</surname><given-names>JE</given-names></name><name><surname>Reck</surname><given-names>MR</given-names></name><name><surname>Prasad</surname><given-names>NK</given-names></name><name><surname>Wencewicz</surname><given-names>TA</given-names></name></person-group><article-title>&#x003b2;-lactone formation during product release from a nonribosomal peptide synthetase</article-title><source>Nat Chem Biol</source><year>2017</year><volume>13</volume><fpage>737</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2374</pub-id><?supplied-pmid 28504677?><pub-id pub-id-type="pmid">28504677</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>TA</given-names></name><name><surname>Heine</surname><given-names>D</given-names></name><name><surname>Qin</surname><given-names>Z</given-names></name><name><surname>Wilkinson</surname><given-names>B</given-names></name></person-group><article-title>An L-threonine transaldolase is required for L-threo-&#x003b2;-hydroxy-&#x003b1;-amino acid assembly during obafluorin biosynthesis</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/ncomms15935</pub-id><pub-id pub-id-type="pmid">28232747</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seiple</surname><given-names>IB</given-names></name><name><surname>Mercer</surname><given-names>JAM</given-names></name><name><surname>Sussman</surname><given-names>RJ</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Myers</surname><given-names>AG</given-names></name></person-group><article-title>Stereocontrolled synthesis of syn-&#x003b2;-hydroxy-&#x003b1;-amino acids by direct aldolization of pseudoephenamine glycinamide</article-title><source>Angew Chem Int Ed</source><year>2014</year><volume>53</volume><fpage>4642</fpage><lpage>4647</lpage><pub-id pub-id-type="doi">10.1002/anie.201400928</pub-id></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singjunla</surname><given-names>Y</given-names></name><name><surname>Baudoux</surname><given-names>J</given-names></name><name><surname>Rouden</surname><given-names>J</given-names></name></person-group><article-title>Direct synthesis of &#x003b2;-hydroxy-&#x003b1;-amino acids via diastereoselective decarboxylative aldol reaction</article-title><source>Org Lett</source><year>2013</year><volume>15</volume><issue>22</issue><fpage>5770</fpage><lpage>5773</lpage><pub-id pub-id-type="doi">10.1021/ol402805f</pub-id><?supplied-pmid 24188057?><pub-id pub-id-type="pmid">24188057</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiyama</surname><given-names>H</given-names></name><name><surname>Shioiri</surname><given-names>T</given-names></name><name><surname>Yokokawa</surname><given-names>F</given-names></name></person-group><article-title>Syntheses of four unusual amino acids, constituents of cyclomarin A</article-title><source>Tetrahedron Lett</source><year>2002</year><volume>43</volume><fpage>3489</fpage><lpage>3492</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(02)00607-X</pub-id></element-citation></ref><ref id="CR45"><mixed-citation publication-type="other">Tailhades J, Zhao Y, Ho YTC, Greule A, Ahmed I, Schoppet M, Kulkarni K, Goode RJA, Schittenhelm RB, Voss JJ, De CMJ (2020) A chemoenzymatic approach to the synthesis of glycopeptide antibiotic analogues. Angew Chem Int Ed:10991&#x02013;10995. 10.1002/ange.202003726</mixed-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ushimaru</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>HW</given-names></name></person-group><article-title>Biosynthetic origin of the atypical stereochemistry in the thioheptose core of albomycin nucleoside antibiotics</article-title><source>J Am Chem Soc</source><year>2019</year><volume>141</volume><fpage>8</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1021/jacs.8b12565</pub-id></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Qu</surname><given-names>X</given-names></name></person-group><article-title>Characterization of a SAM-dependent fluorinase from a latent biosynthetic pathway for fluoroacetate and 4-fluorothreonine formation in <italic>Nocardia brasiliensis</italic></article-title><source>F1000Research</source><year>2014</year><volume>3</volume><fpage>61</fpage><pub-id pub-id-type="doi">10.12688/f1000research.3-61.v1</pub-id><?supplied-pmid 24795808?><pub-id pub-id-type="pmid">24795808</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winn</surname><given-names>M</given-names></name><name><surname>Goss</surname><given-names>RJM</given-names></name><name><surname>Kimura</surname><given-names>KI</given-names></name><name><surname>Bugg</surname><given-names>TDH</given-names></name></person-group><article-title>Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis</article-title><source>Nat Prod Rep</source><year>2010</year><volume>27</volume><fpage>279</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1039/b816215h</pub-id><?supplied-pmid 20111805?><pub-id pub-id-type="pmid">20111805</pub-id></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Maglangit</surname><given-names>F</given-names></name><name><surname>Deng</surname><given-names>H</given-names></name></person-group><article-title>Fluorine biocatalysis</article-title><source>Curr Opin Chem Biol</source><year>2020</year><volume>55</volume><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2020.01.004</pub-id><?supplied-pmid 32087550?><pub-id pub-id-type="pmid">32087550</pub-id></element-citation></ref><ref id="CR50"><mixed-citation publication-type="other">Wu L, Tong MH, Kyeremeh K (2020) Identification of 5-fluoro-5-deoxy-ribulose as a shunt fluorometabolite in <italic>Streptomyces</italic> sp. MA37. Biomolecules. 1&#x02013;11. 10.3390/biom10071023</mixed-citation></ref><ref id="CR51"><mixed-citation publication-type="other">Wu L, Tong MH, Raab A, Fang Q, Wang S, Kyeremeh K, Yu Y, Deng H (2020) An unusual metal-bound 4-fluorothreonine transaldolase from <italic>Streptomyces</italic> sp. MA37 catalyses promiscuous transaldol reactions. Appl Microbiol Biotechnol. 10.1007/s00253-020-10497-z</mixed-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>LC</given-names></name><name><surname>Su</surname><given-names>BM</given-names></name><name><surname>Xu</surname><given-names>XQ</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name></person-group><article-title>Multi-enzyme cascade for improving &#x003b2;-hydroxy-&#x003b1;-amino acids production by engineering L-threonine transaldolase and combining acetaldehyde elimination system</article-title><source>Bioresour Technol</source><year>2020</year><volume>310</volume><fpage>123439</fpage><pub-id pub-id-type="doi">10.1016/j.biortech.2020.123439</pub-id><?supplied-pmid 32361648?><pub-id pub-id-type="pmid">32361648</pub-id></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>LC</given-names></name><name><surname>Xu</surname><given-names>XQ</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name></person-group><article-title>Characteristics of L-threonine transaldolase for asymmetric synthesis of &#x003b2;-hydroxy-&#x003b1;-amino acids</article-title><source>Catal Sci Technol</source><year>2019</year><volume>9</volume><fpage>5943</fpage><lpage>5952</lpage><pub-id pub-id-type="doi">10.1039/c9cy01608b</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name></person-group><article-title>From molecular engineering to process engineering: development of high-throughput screening methods in enzyme directed evolution</article-title><source>Appl Microbiol Biotechnol</source><year>2018</year><volume>102</volume><fpage>559</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1007/s00253-017-8568-y</pub-id><?supplied-pmid 29181567?><pub-id pub-id-type="pmid">29181567</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yim</surname><given-names>G</given-names></name><name><surname>Thaker</surname><given-names>MN</given-names></name><name><surname>Koteva</surname><given-names>K</given-names></name><name><surname>Wright</surname><given-names>G</given-names></name></person-group><article-title>Glycopeptide antibiotic biosynthesis</article-title><source>J Antibiot (Tokyo)</source><year>2014</year><volume>67</volume><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/ja.2013.117</pub-id><pub-id pub-id-type="pmid">24220108</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Ou</surname><given-names>H</given-names></name><name><surname>Mcglinchey</surname><given-names>RP</given-names></name><name><surname>Hagan</surname><given-names>DO</given-names></name></person-group><article-title>Insights into fluorometabolite biosynthesis in <italic>Streptomyces cattleya</italic> DSM46488 through genome sequence and knockout mutants</article-title><source>Bioorg Chem</source><year>2012</year><volume>44</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2012.06.002</pub-id><?supplied-pmid 22858315?><pub-id pub-id-type="pmid">22858315</pub-id></element-citation></ref></ref-list></back></article>